Literature DB >> 9748040

Ahomocysteinemia in molybdenum cofactor deficiency.

W D Graf1, O E Oleinik, R M Jack, A H Weiss, J L Johnson.   

Abstract

We report an infant with molybdenum cofactor deficiency (MCD) and a unique clinical presentation of hemiplegia, hypotonia, dystonia, and bilateral basal ganglia changes. Biochemistry revealed absent serum homocysteine, low concentrations of plasma cystine, high levels of urinary S-sulfocysteine and sulfite, and high levels of oxypurines in serum and urine. The depletion of cysteine and cystine through reaction with sulfite suggests that other thiols and thiol-dependent proteins may be similarly depleted. Ahomocysteinemia may be a clue to the mechanism of cytotoxicity in MCD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748040     DOI: 10.1212/wnl.51.3.860

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Hypohomocysteinaemia and highly increased proportion of S-sulfonated plasma transthyretin in molybdenum cofactor deficiency.

Authors:  J O Sass; M Kishikawa; R Puttinger; J Reiss; W Erwa; A Shimizu; W Sperl
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

2.  Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.

Authors:  Joanna Jakubiczka-Smorag; Jose Angel Santamaria-Araujo; Imke Metz; Avadh Kumar; Samy Hakroush; Wolfgang Brueck; Guenter Schwarz; Peter Burfeind; Jochen Reiss; Lukasz Smorag
Journal:  Hum Genet       Date:  2016-05-02       Impact factor: 4.132

3.  Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature.

Authors:  Barbara Scelsa; Serena Gasperini; Andrea Righini; Maria Iascone; Valeria G Brazzoduro; Pierangelo Veggiotti
Journal:  Mol Genet Genomic Med       Date:  2019-03-21       Impact factor: 2.183

4.  The effect of dietary protein restriction in a case of molybdenum cofactor deficiency with MOCS1 mutation.

Authors:  Yu Abe; Yu Aihara; Wakaba Endo; Hiroshi Hasegawa; Kimiyoshi Ichida; Mitsugu Uematsu; Shigeo Kure
Journal:  Mol Genet Metab Rep       Date:  2021-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.